We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management

By LabMedica International staff writers
Posted on 17 Dec 2024

Millions of individuals with diabetes monitor their glucose levels daily using finger-stick devices that draw and analyze blood. More...

But imagine if this could be done with just a sweat sensor. This is the concept behind new research that could change diabetes management by eliminating the discomfort and inconvenience of traditional methods.

Traditional glucose monitoring systems use enzymatic reactions with blood samples, but these methods are not shelf-stable, making them difficult to store and ship. The self-replicating properties of bacteria, however, offer a potential solution. Researchers at Binghamton University (New York, NY, USA) have developed a new paper-based biosensor system that uses Bacillus subtilis bacterial spores, which germinate in response to glucose in potassium-rich fluids like sweat. The power generated by the spores indicates the glucose level, and the system can withstand harsh environments, activating only when the right conditions are met. This novel approach could transform diabetes management by eliminating the need for painful finger-stick blood samples.

The research team had previously used paper as a platform to create detectors for lead ions in seawater. Their earlier work also includes integrating biobatteries into 3D-printed circuits, creating devices that generate moisture from the air, and designing self-powered mechanical bugs for collecting ocean data. In light of the current global energy crisis, using bacteria to generate power presents a promising, sustainable solution. Since the biosensor is paper-based and disposable, it is cost-effective and simple to use. After publishing their findings in the journal Microsystems & Nanoengineering, the researchers are now working on refining the detection process further.

“Everyone has a different potassium concentration in their sweat, and I don’t know how this concentration affects the glucose,” said Professor Seokheun “Sean” Choi, who adapted the knowledge of biobatteries gained in his Bioelectronics and Microsystems Lab over the past 15 years to build the paper-based biosensor system. “The sensitivity also is lower than conventional enzymatic biosensors. But from this work, we created a new sensing mechanism to detect glucose. No one has done that yet.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automated Urinalysis Solution
UN-9000
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.